You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

PTAB Cases from Apotex Inc.


✉ Email this page to a colleague

« Back to Dashboard


Patent Trial and Appeal Board Cases for Petitioner: Apotex Inc.

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
5,691,336 Apotex Inc. ⤷  Sign Up 2014-12-11 12-11-2014 Merck Sharp & Dohme Corp. Inter partes review ⤷  Sign Up 06-25-2015 CONRAD DORN ⤷  Sign Up
6,716,830 Apotex Inc. ⤷  Sign Up 2012-10-05 10-04-2012 Alcon Pharmaceuticals Ltd. Inter partes review ⤷  Sign Up 03-19-2013 Gerald Cagle ⤷  Sign Up
7,671,070 Apotex Inc. ⤷  Sign Up 2012-10-12 10-12-2012 Alcon Inter partes review ⤷  Sign Up 03-19-2013 Gerald Cagle ⤷  Sign Up
7,772,209 Apotex Inc. ⤷  Sign Up 2016-07-01 07-01-2016 Inter partes review ⤷  Sign Up 09-30-2016 Clet Niyikiza ⤷  Sign Up
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.